Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The sandwich stores and salad bars of Britain are still tormenting us with coronation chicken, a recipe originally created as a dish for George V’s silver jubilee, and later updated and rebranded “coronation...
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Is a Covid-19 silver bullet almost ready to be fired? Judging by the frenzied rally in global stock markets on Monday, one might think so....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...That time Pfizer failed to clinch a deal for AstraZeneca If Ian Read had his way, AstraZeneca would be a unit of US pharma group Pfizer right now....
...There were three major acquisitions in the industry last year, with Vice Media buying Refinery29, Vox Media buying New York Media and GroupNine Media Inc. buying PopSugar....
...AstraZeneca may have been unable to fully realise the medicine’s potential without this partnership, Mr Leuchten noted: “These guys have been doing a lot of deals where they’ve been selling the family silver...
...Saigon Saigon 313-317 King Street Hammersmith, London W6 Set lunch x 2 £23 Sparkling water £4.25 Total (inc tip) £30.66 Our starters and jasmine teas arrive....
...The deal announced on Monday will give Michael Dell and his financial partner Silver Lake, the tech-focused private equity group, greater control of VMware, the data centre company it already controls....
...Silver Run Acquisition Corp II, which has since bought two energy companies, raised more than $1bn in the year’s biggest Spac listing....
...In 2010, after three years’ sales of silver-edged iPhones, Apple overtook Microsoft’s market value of $229bn....
...(FT) Japan Inc goes global for M&A advice Only three domestic brokerages rank among the top-ten deal advisers in Japan during the third quarter. Why is Japan Inc looking for foreign advice?...
...“Immunotherapy is not a silver bullet,” says Bob Hugin, chairman of Celgene, the biotech company. “Checkpoint inhibitors only work in a minority of patients.”...
...Although Class V investors will be able to vote for the independent directors, shares owned by Mr Dell and Silver Lake, the buyout firm that supported his EMC deal, have 10 times the voting rights, diluting...
...Trailing the loping, silver-haired Democrat closely as he works the crowd at Omaha’s annual El Grito parade is a translator who repeats quietly in Spanish: “His name is Brad Ashford....
...Spot silver fell 0.7 per cent on Thursday, extending to 10 per cent its fall in the last month....
...economic benefits based, directly or indirectly, on the value or price of, any capital stock of, or other securities or ownership interests in, the Company (the items in clauses (i), (ii), (iii), (iv) and (v)...
...Companies have lost hundreds of millions of dollars in failed trials, leading some such as Pfizer and Sanofi to drop out of the race. Others have doubled-down....
...The report follows a spate of dealmaking in the sector, including the unsuccessful $40bn offer from Pfizer of the US for AstraZeneca and the proposed $50bn merger of Ireland’s Coiven with American medical...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...One of Dell’s largest shareholders stated its opposition to the proposed $24.4bn buyout by Michael Dell and Silver Lake Partners. T Rowe Price owns 4.4 per cent of Dell stock....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Citigroup analysts said Pfizer would retain 50 per cent market share this year....
International Edition